SLGL logo

SLGL Sol-Gel Technologies Ltd.

NASDAQ Global Market · Biotechnology · Healthcare

$55.12
-1.13 (-2.01%)

Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, …

Market Cap: $180.46Mwww.sol-gel.com

Price

No data yet.

Social Signal Score

44
5d
—
30d
30
1 mentions
—
60d
52
4 mentions
—
90d
51
5 mentions
—
news: 5

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 1Sell 0Strong Sell 0
Avg price target$110+99.6%
Low $110Median $110High $110
Current Consensus

Revenue

$41.0K
$-2.0K$6.93M$13.87M$20.81M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.74
$-1.16–$-0.32
1 analysts
FY2026
$-7.76
$-8.36–$-7.15
2 analysts
FY2027
$-9.07
$-11.35–$-7.91
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Moshe Arkin
Sector
Healthcare
Industry
Biotechnology
Employees
28
Beta
1.24
Country
IL
Piotroski score
2 / 9 (Weak)
Altman Z-score
7.53
www.sol-gel.com